Press Release

EDCTP and CEPI funding moves IAVI’s Lassa fever vaccine candidate into advanced clinical development

Global consortium of expert partners will generate proof-of-concept data to support product licensure and future access NEW YORK, THE HAGUE, AND OSLO – JUNE 15, 2021 – IAVI has received an award of €22.8 million from the European & Developing Countries Clinical Trials Partnership (EDCTP) and the Coalition for Epidemic Preparedness Innovations (CEPI) to conduct […]